| 產(chǎn)品名稱 | BMS 204352 - Flindokalner | BMS 204352, (S)-(+)- | MaxiPost |
| 產(chǎn)品貨號(hào) | Axon 1112 CAS [187523-35-9] MF C16H10ClF4NO2MW 359.70 Purity: 99% Optical purity: 99% ee Soluble in DMSO Description Maxi-K channel opener, potential therapeutic for the treatment of stroke; more active S-(+)-enantiomer in comparison with R-(-)-enantiomer (Axon 1309) References Certificates Categories Extra info R Krishna et al. Pharmacokinetics and dose proportionality of BMS-204352 after intraarterial administration to rats.?Biopharm. Drug Dispos. 2002,?23(6), 233-7. ? MPG Korsgaard et al.?Anxiolytic Effects of Maxipost (BMS-204352) and Retigabine via Activation of Neuronal Kv7 Channels.?J. Pharmacol. Exp. Ther.2005, 314, 282-292. ? YK Son et al. The inhibitory effect of Ca2+-activated K+ channel activator, BMS on L-type Ca2+ channels in rat ventricular myocytes. Life sciences, 2011, 89(9), 331-336.?(*BMS204352 used in this study is procured from Axon Medchem.) Certificate of Analysis Material Safety Data Sheet Cardiovascular CNS KCa1.1 KCNMA1 Maxi K+ channel opener Chemical name (S)-3-(5-Chloro-2-methoxy-phenyl)-3-fluoro-6-trifluoromethyl-1,3-dihydro-indol-2-one Parent CAS No. [187523-35-9] Order Size Unit Price Stock 5 mg €105.00 In Stock |
| 產(chǎn)品價(jià)格 | 現(xiàn)貨詢價(jià)，電話：010-67529703 |
| 產(chǎn)品規(guī)格 | |
| 產(chǎn)品品牌 | axonmedchem |
| 產(chǎn)品概述 | |
| 產(chǎn)品詳情 |
BMS 204352 - Flindokalner | BMS 204352, (S)-(+)- | MaxiPostAxon 1112 CAS [187523-35-9] MF C16H10ClF4NO2
DescriptionMaxi-K channel opener, potential therapeutic for the treatment of stroke; more active S-(+)-enantiomer in comparison with R-(-)-enantiomer (Axon 1309)
Maxi K+ channel opener
Chemical name(S)-3-(5-Chloro-2-methoxy-phenyl)-3-fluoro-6-trifluoromethyl-1,3-dihydro-indol-2-one Parent CAS No.[187523-35-9] |
| 產(chǎn)品資料 |
